Monarch Partners Asset Management’s Health Catalyst HCAT Stock Holding History

Monarch Partners Asset Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-144,342	Closed	-$7.22M	–	167
2021 Q3	$7.22M	Buy	144,342 +14,830	+11%	+$809K	1.05%	34
2021 Q2	$7.19M	Buy	129,512 +26,417	+26%	+$1.41M	1.03%	37
2021 Q1	$4.82M	Sell	103,095 -6,776	-6%	-$328K	0.73%	68
2020 Q4	$4.78M	Sell	109,871 -44,976	-29%	-$1.66M	0.84%	49
2020 Q3	$5.67M	Sell	154,847 -2,870	-2%	-$97.5K	1.28%	22
2020 Q2	$4.6M	Buy	+157,717	New	+$4.36M	1.12%	39

Other funds holding HCAT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Monarch Partners Asset Management's HCAT Position: Q4 2021 in Review

Monarch Partners Asset Management sold out of Health Catalyst (HCAT) in Q4 2021, closing a stake of 144,342 shares — an estimated $7.22M sold.

Monarch Partners Asset Management first reported a position in HCAT in Q2 2020 and held it in 6 quarters. The position peaked at $7.22M in Q3 2021. 187 funds tracked by Wall St. Rank hold HCAT as of Q4 2021.

Monarch Partners Asset Management reported no remaining Health Catalyst position as of Q4 2021 after selling out during the quarter.
Monarch Partners Asset Management sold 144,342 Health Catalyst shares in Q4 2021, an estimated $7.22M.
Monarch Partners Asset Management first reported a position in Health Catalyst in Q2 2020 and held it in 6 quarters.
Monarch Partners Asset Management's Health Catalyst position peaked at $7.22M in Q3 2021.
187 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2021.

Based on Monarch Partners Asset Management's 13F filing for Q4 2021, filed 3 Feb 2022.